Morgan Stanley

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
34,641
Total Value
881484701630
Accession Number
0000895421-25-000381
Form Type
13F-HR
Manager Name
Morgan Stanley
Data Enrichment
83% identified
28,652 identified5,989 unidentified

Holdings

34,641 positions
Manager:
Search and click to pin securities to the top
Page 349 of 405
Calidi Biotherapeutics, Inc.
Shares:
2019(-19.9%)
Value:
$1.1M(-60.5%)
G6202B101
Shares:
1482(+1.7%)
Value:
$1.1M(-30.0%)
37954Y699
Shares:
71(+0.0%)
Value:
$1.1M(+14.6%)
25459Y280
Shares:
41(+1950.0%)
Value:
$1.1M(+2193.8%)
G6781F101
Shares:
1550
Value:
$1.1M
GLYCOMIMETICS INC
Shares:
5176(+0.0%)
Value:
$1.1M(-15.7%)
FTC Solar, Inc.
Shares:
377(-91.1%)
Value:
$1.1M(-95.3%)
G7244A119
Shares:
2627(+12.5%)
Value:
$1.1M(-64.5%)
74347G150
Shares:
32
Value:
$1.0M
74349Y712
Shares:
26(+8.3%)
Value:
$1.0M(+3.8%)
46429B416
Shares:
30(-82.5%)
Value:
$1.0M(-82.5%)
35101A309
Shares:
101(+1.0%)
Value:
$1.0M(-2.2%)
Bogota Financial Corp.
Shares:
131
Value:
$1.0M
34385PAA6
Shares:
0
Value:
$987.0K(-0.2%)
26923G780
Shares:
41
Value:
$986.0K
INTENSITY THERAPEUTICS, INC.
Shares:
500(+0.0%)
Value:
$985.0K(+11.9%)
Nexalin Technology, Inc.
Shares:
500
Value:
$975.0K
25460E737
Shares:
18(+800.0%)
Value:
$971.0K(+722.9%)
ORAGENICS INC
Shares:
4593(+5.9%)
Value:
$965.0K(-39.8%)
83304AAB2
Shares:
0
Value:
$962.0K(-0.8%)